Inventor
DAEMMGEN JUERGEN
DE12 patents
⚠️ This page may combine multiple inventors who share the name “DAEMMGEN JUERGEN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
DAEMMGEN JUERGEN
6 patentsUS8980894B2Mar 17, 2015
Use of PDE III inhibitors for the treatment of asymptomatic (occult) heart failure
DAEMMGEN JUERGEN16 citations88
US9889148B2Feb 13, 2018
Use of pimobendan for the reduction of heart size in mammals suffering from heart failure
DAEMMGEN JUERGEN7 citations81
US8883123B2Nov 11, 2014
Use of vaccines for the treatment/prevention of the transmission of pathogens
DAEMMGEN JUERGEN4 citations71
US9463199B2Oct 11, 2016
Use of PDE III inhibitors for the reduction of heart size in mammals suffering from heart failure
DAEMMGEN JUERGEN3 citations70
US10117869B2Nov 6, 2018
PDE III inhibitors for treatment of asymptomatic heart failure
DAEMMGEN JUERGEN4 citations68
US8664252B2Mar 4, 2014
Phosphodiesterase type III (PDE III) inhibitors or CA2+-sensitizing agents for the treatment of hypertrophic cardiomyopathy
DAEMMGEN JUERGEN0 citations49